DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 127 filers reported holding DIPLOMAT PHARMACY INC in Q2 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,538,000 | -20.4% | 1,134,345 | -2.5% | 0.01% | -28.6% |
| Q3 2019 | $5,703,000 | -5.4% | 1,164,007 | +17.6% | 0.01% | -12.5% |
| Q2 2019 | $6,030,000 | +35.5% | 990,173 | +29.2% | 0.01% | +33.3% |
| Q1 2019 | $4,451,000 | +614.4% | 766,106 | +1555.1% | 0.01% | +500.0% |
| Q4 2018 | $623,000 | -88.3% | 46,287 | -83.1% | 0.00% | -83.3% |
| Q3 2018 | $5,320,000 | +370.8% | 274,104 | +519.8% | 0.01% | +500.0% |
| Q2 2018 | $1,130,000 | -78.4% | 44,223 | -83.0% | 0.00% | -85.7% |
| Q1 2018 | $5,226,000 | -53.6% | 259,383 | -53.8% | 0.01% | -56.2% |
| Q4 2017 | $11,260,000 | +66.0% | 561,041 | +71.3% | 0.02% | +60.0% |
| Q3 2017 | $6,785,000 | +17.4% | 327,585 | -16.1% | 0.01% | 0.0% |
| Q2 2017 | $5,781,000 | +1483.8% | 390,589 | +1605.8% | 0.01% | +900.0% |
| Q1 2017 | $365,000 | -64.5% | 22,898 | -23.7% | 0.00% | -50.0% |
| Q4 2015 | $1,027,000 | +257.8% | 30,000 | +200.0% | 0.00% | – |
| Q3 2015 | $287,000 | -77.3% | 10,000 | -72.7% | 0.00% | -100.0% |
| Q1 2015 | $1,266,000 | +92.4% | 36,599 | +52.1% | 0.00% | +100.0% |
| Q4 2014 | $658,000 | – | 24,059 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|